AORT insider sale notice: 18,200 shares via Morgan Stanley, option exercise
Rhea-AI Filing Summary
Artivion, Inc. (AORT) Form 144 discloses a proposed sale of 18,200 common shares through Morgan Stanley Smith Barney with an aggregate market value of $801,211.32. The shares were acquired and are listed for sale with an approximate sale date of 08/27/2025 following a stock option exercise paid in cash on the same date. The filing shows total shares outstanding of 47,183,658 and lists two prior sales by the same person in June 2025 of 15,000 and 26,132 shares, with gross proceeds of $442,500.00 and $743,129.66 respectively.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell 18,200 shares after exercising options, adding to prior June sales; proceeds are disclosed and routine under Rule 144.
The filing shows a routine Rule 144 notice: the shares were acquired by stock option exercise on 08/27/2025 and payment was made in cash. The proposed sale via Morgan Stanley lists an aggregate value of $801,211.32. Prior dispositions in June 2025 totaled 41,132 shares with combined gross proceeds of $1,185,629.66. Relative to the issuer's outstanding shares (47,183,658), these transactions represent a small fraction of total equity, indicating limited dilution or control change.
TL;DR: Filing presents standard Rule 144 disclosures and includes the required certification regarding material nonpublic information.
The notice includes the required representation that the seller is not aware of undisclosed material adverse information and references Rule 10b5-1 trading-plan language. The signature/representation language and broker details (Morgan Stanley Smith Barney) are present, satisfying procedural disclosure norms. No regulatory violations or unusual payment arrangements are disclosed; the acquisition and payment are recorded as a cash-funded option exercise on the same date as the proposed sale.